|
ZA836080B
(en)
*
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
WO1994016109A1
(en)
*
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
|
WO1994017826A1
(en)
*
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
|
US5573916A
(en)
*
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
EP1500329B1
(en)
|
1996-12-03 |
2012-03-21 |
Amgen Fremont Inc. |
Human antibodies that specifically bind human TNF alpha
|
|
US6165476A
(en)
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
CA2365592C
(en)
|
1999-04-29 |
2011-11-15 |
Zeneca Limited |
Herbicide resistant plants comprising epsps
|
|
TR200200776T2
(tr)
*
|
1999-09-24 |
2002-06-21 |
Smithkline Beecham Biologicals S.A. |
Burun içi grip virüsü aşısı.
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
MXPA02010642A
(es)
*
|
2000-04-28 |
2004-05-17 |
St Jude Children S Res Hospital |
Sistema de transfeccion de adn para la generacion de virus de influenza infeccioso.
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
AU2003219745B8
(en)
|
2002-02-13 |
2008-10-09 |
Wisconsin Alumni Research Foundation |
Signal for packaging of influenza virus vectors
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
CA2514177A1
(en)
|
2003-01-29 |
2004-08-12 |
Josef Michl |
Tolerance-induced targeted antibody production
|
|
ATE426412T1
(de)
*
|
2003-01-30 |
2009-04-15 |
Novartis Vaccines & Diagnostic |
Adjuvante influenza-vakzine
|
|
JP4368594B2
(ja)
*
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
|
ATE473271T1
(de)
|
2003-05-05 |
2010-07-15 |
Thompson Boyce Plant Res |
Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
DK1692265T3
(da)
*
|
2003-11-04 |
2011-11-21 |
Univ Tulane |
Fremgangsmåde til hindring af en virus-celle-fusion ved hæmning af fusionsinitieringsområdets funktion i RNA-vira med klasse 1-membranfusogene envelopeproteiner
|
|
CA2879182C
(en)
*
|
2004-05-25 |
2017-02-14 |
Medimmune, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
EP1851238A4
(en)
*
|
2005-02-24 |
2008-12-31 |
Univ Massachusetts |
FLUID NUCLEIC ACIDS, POLYPEPTIDES AND USES THEREOF
|
|
AU2006252406B2
(en)
|
2005-06-01 |
2012-05-17 |
California Institute Of Technology |
Method of targeted gene delivery using viral vectors
|
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
|
NZ568211A
(en)
*
|
2005-11-04 |
2011-11-25 |
Novartis Vaccines & Diagnostic |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
KR101492643B1
(ko)
|
2005-12-02 |
2015-02-12 |
이칸 스쿨 오브 메디슨 엣 마운트 시나이 |
비-천연 표면 단백질을 제시하는 키메라 바이러스 및 그의용도
|
|
WO2007066334A1
(en)
*
|
2005-12-06 |
2007-06-14 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved influenza vaccine
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
US20070224205A1
(en)
|
2006-03-07 |
2007-09-27 |
Powell Thomas J |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
EP2024393A2
(en)
|
2006-05-15 |
2009-02-18 |
Sea Lane Biotechnologies,llc. |
Neutralizing antibodies to influenza viruses
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
US9511134B2
(en)
*
|
2006-05-18 |
2016-12-06 |
Epimmune Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
WO2008005777A2
(en)
|
2006-06-30 |
2008-01-10 |
Novavax, Inc. |
Methods of enhancing protein incorporation into virus like particles
|
|
BRPI0714495B8
(pt)
|
2006-07-21 |
2021-05-25 |
California Inst Of Techn |
lentivírus deficiente para replicação recombinante pseudotipado
|
|
JP5161882B2
(ja)
|
2006-09-07 |
2013-03-13 |
クルセル ホランド ベー ヴェー |
インフルエンザウイルスｈ５ｎ１を中和しうるヒト結合性分子およびその使用
|
|
ES2536401T3
(es)
|
2006-09-11 |
2015-05-25 |
Novartis Ag |
Fabricación de vacunas contra virus de la gripe sin usar huevos
|
|
EP2716656B1
(en)
*
|
2007-06-15 |
2016-10-12 |
Xiamen University |
Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
|
|
EP2014279A1
(en)
*
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
WO2009025770A2
(en)
|
2007-08-17 |
2009-02-26 |
Wyeth |
A heterologous prime-boost immunization regimen
|
|
WO2009088401A2
(en)
*
|
2007-09-24 |
2009-07-16 |
Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Immunostimulatory combinations of tlr ligands and methods of use
|
|
FR2921387B1
(fr)
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
EP2238253B1
(en)
|
2007-11-27 |
2012-09-12 |
Medicago Inc. |
Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
|
|
EP3524619A1
(en)
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
WO2009121004A2
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
|
EP2540740B1
(en)
*
|
2008-06-17 |
2014-09-10 |
Apogenix GmbH |
Multimeric TNF receptors
|
|
PL2300609T3
(pl)
|
2008-06-25 |
2014-05-30 |
Inst Nat Sante Rech Med |
Nowe związki na bazie flageliny o charakterze immunoadiuwantów i ich zastosowanie
|
|
DK2294202T3
(en)
|
2008-07-08 |
2015-08-31 |
Medicago Inc |
SOLUBLE RECOMBINANT INFLUENZA ANTIGENES
|
|
EP3009145A1
(en)
*
|
2009-03-30 |
2016-04-20 |
Mount Sinai School of Medicine of New York University |
Influenza virus vaccines and uses thereof
|
|
AU2010247530B2
(en)
|
2009-05-11 |
2016-10-13 |
Janssen Vaccines & Prevention B.V. |
Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
|
|
AU2010254136B2
(en)
*
|
2009-05-26 |
2016-09-29 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
HRP20180706T1
(hr)
|
2009-06-24 |
2018-06-01 |
Medicago Inc. |
Kimerna gripa nalik čestici koja sadrži hemaglutinin
|
|
US8828406B2
(en)
*
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
|
US8298820B2
(en)
*
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
CA2790380A1
(en)
|
2010-02-18 |
2011-08-25 |
Mount Sinai School Of Medicine |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
WO2011111966A2
(en)
|
2010-03-08 |
2011-09-15 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
|
|
EP3248615A1
(en)
*
|
2010-03-30 |
2017-11-29 |
Mount Sinai School of Medicine of New York University |
Influenza virus vaccines and uses thereof
|
|
ES2739711T3
(es)
|
2010-07-22 |
2020-02-03 |
John W Schrader |
Anticuerpo de protección cruzada contra la infección por el virus de la gripe
|
|
IN2014CN02114A
(https=)
|
2011-09-20 |
2015-05-29 |
Sinai School Medicine |
|
|
CA2857087C
(en)
|
2011-11-28 |
2021-05-25 |
Crucell Holland B.V. |
Influenza virus vaccines and uses thereof
|
|
CA2894506C
(en)
|
2012-12-11 |
2021-08-10 |
Vib Vzw |
Anti-influenza antibody
|
|
EA201591164A1
(ru)
|
2012-12-18 |
2015-11-30 |
Икан Скул Оф Медсин Эт Маунт Синай |
Вакцины против вируса гриппа и их применение
|